2021-04-012022-03-312022-03-31false03166043HILTON PHARMACY LIMITED2022-08-1947730iso4217:GBPxbrli:pure031660432021-04-01031660432022-03-31031660432021-04-012022-03-31031660432020-04-01031660432021-03-31031660432020-04-012021-03-3103166043bus:SmallEntities2021-04-012022-03-3103166043bus:AuditExempt-NoAccountantsReport2021-04-012022-03-3103166043bus:FullAccounts2021-04-012022-03-3103166043bus:PrivateLimitedCompanyLtd2021-04-012022-03-3103166043core:WithinOneYear2022-03-3103166043core:AfterOneYear2022-03-3103166043core:WithinOneYear2021-03-3103166043core:AfterOneYear2021-03-3103166043core:ShareCapital2022-03-3103166043core:SharePremium2022-03-3103166043core:RevaluationReserve2022-03-3103166043core:OtherReservesSubtotal2022-03-3103166043core:RetainedEarningsAccumulatedLosses2022-03-3103166043core:ShareCapital2021-03-3103166043core:SharePremium2021-03-3103166043core:RevaluationReserve2021-03-3103166043core:OtherReservesSubtotal2021-03-3103166043core:RetainedEarningsAccumulatedLosses2021-03-3103166043core:LandBuildings2022-03-3103166043core:PlantMachinery2022-03-3103166043core:Vehicles2022-03-3103166043core:FurnitureFittings2022-03-3103166043core:OfficeEquipment2022-03-3103166043core:NetGoodwill2022-03-3103166043core:IntangibleAssetsOtherThanGoodwill2022-03-3103166043core:ListedExchangeTraded2022-03-3103166043core:UnlistedNon-exchangeTraded2022-03-3103166043core:LandBuildings2021-03-3103166043core:PlantMachinery2021-03-3103166043core:Vehicles2021-03-3103166043core:FurnitureFittings2021-03-3103166043core:OfficeEquipment2021-03-3103166043core:NetGoodwill2021-03-3103166043core:IntangibleAssetsOtherThanGoodwill2021-03-3103166043core:ListedExchangeTraded2021-03-3103166043core:UnlistedNon-exchangeTraded2021-03-3103166043core:LandBuildings2021-04-012022-03-3103166043core:PlantMachinery2021-04-012022-03-3103166043core:Vehicles2021-04-012022-03-3103166043core:FurnitureFittings2021-04-012022-03-3103166043core:OfficeEquipment2021-04-012022-03-3103166043core:NetGoodwill2021-04-012022-03-3103166043core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3103166043core:ListedExchangeTraded2021-04-012022-03-3103166043core:UnlistedNon-exchangeTraded2021-04-012022-03-3103166043core:MoreThanFiveYears2021-04-012022-03-3103166043core:Non-currentFinancialInstruments2022-03-3103166043core:Non-currentFinancialInstruments2021-03-3103166043dpl:CostSales2021-04-012022-03-3103166043dpl:DistributionCosts2021-04-012022-03-3103166043dpl:AdministrativeExpenses2021-04-012022-03-3103166043core:LandBuildings2021-04-012022-03-3103166043core:PlantMachinery2021-04-012022-03-3103166043core:Vehicles2021-04-012022-03-3103166043core:FurnitureFittings2021-04-012022-03-3103166043core:OfficeEquipment2021-04-012022-03-3103166043core:NetGoodwill2021-04-012022-03-3103166043core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3103166043dpl:GroupUndertakings2021-04-012022-03-3103166043dpl:ParticipatingInterests2021-04-012022-03-3103166043dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3103166043core:ListedExchangeTraded2021-04-012022-03-3103166043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3103166043core:UnlistedNon-exchangeTraded2021-04-012022-03-3103166043dpl:CostSales2020-04-012021-03-3103166043dpl:DistributionCosts2020-04-012021-03-3103166043dpl:AdministrativeExpenses2020-04-012021-03-3103166043core:LandBuildings2020-04-012021-03-3103166043core:PlantMachinery2020-04-012021-03-3103166043core:Vehicles2020-04-012021-03-3103166043core:FurnitureFittings2020-04-012021-03-3103166043core:OfficeEquipment2020-04-012021-03-3103166043core:NetGoodwill2020-04-012021-03-3103166043core:IntangibleAssetsOtherThanGoodwill2020-04-012021-03-3103166043dpl:GroupUndertakings2020-04-012021-03-3103166043dpl:ParticipatingInterests2020-04-012021-03-3103166043dpl:GroupUndertakingscore:ListedExchangeTraded2020-04-012021-03-3103166043core:ListedExchangeTraded2020-04-012021-03-3103166043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2020-04-012021-03-3103166043core:UnlistedNon-exchangeTraded2020-04-012021-03-3103166043core:NetGoodwill2022-03-3103166043core:IntangibleAssetsOtherThanGoodwill2022-03-3103166043core:LandBuildings2022-03-3103166043core:PlantMachinery2022-03-3103166043core:Vehicles2022-03-3103166043core:FurnitureFittings2022-03-3103166043core:OfficeEquipment2022-03-3103166043core:AfterOneYear2022-03-3103166043core:WithinOneYear2022-03-3103166043core:ListedExchangeTraded2022-03-3103166043core:UnlistedNon-exchangeTraded2022-03-3103166043core:ShareCapital2022-03-3103166043core:SharePremium2022-03-3103166043core:RevaluationReserve2022-03-3103166043core:OtherReservesSubtotal2022-03-3103166043core:RetainedEarningsAccumulatedLosses2022-03-3103166043core:NetGoodwill2021-03-3103166043core:IntangibleAssetsOtherThanGoodwill2021-03-3103166043core:LandBuildings2021-03-3103166043core:PlantMachinery2021-03-3103166043core:Vehicles2021-03-3103166043core:FurnitureFittings2021-03-3103166043core:OfficeEquipment2021-03-3103166043core:AfterOneYear2021-03-3103166043core:WithinOneYear2021-03-3103166043core:ListedExchangeTraded2021-03-3103166043core:UnlistedNon-exchangeTraded2021-03-3103166043core:ShareCapital2021-03-3103166043core:SharePremium2021-03-3103166043core:RevaluationReserve2021-03-3103166043core:OtherReservesSubtotal2021-03-3103166043core:RetainedEarningsAccumulatedLosses2021-03-3103166043core:NetGoodwill2020-04-0103166043core:IntangibleAssetsOtherThanGoodwill2020-04-0103166043core:LandBuildings2020-04-0103166043core:PlantMachinery2020-04-0103166043core:Vehicles2020-04-0103166043core:FurnitureFittings2020-04-0103166043core:OfficeEquipment2020-04-0103166043core:AfterOneYear2020-04-0103166043core:WithinOneYear2020-04-0103166043core:ListedExchangeTraded2020-04-0103166043core:UnlistedNon-exchangeTraded2020-04-0103166043core:ShareCapital2020-04-0103166043core:SharePremium2020-04-0103166043core:RevaluationReserve2020-04-0103166043core:OtherReservesSubtotal2020-04-0103166043core:RetainedEarningsAccumulatedLosses2020-04-0103166043core:AfterOneYear2021-04-012022-03-3103166043core:WithinOneYear2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:CostValuation2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-04-012022-03-3103166043core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3103166043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3103166043core:Non-currentFinancialInstrumentscore:CostValuation2021-03-3103166043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-03-3103166043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-03-3103166043bus:Director12021-04-012022-03-3103166043bus:Director22021-04-012022-03-3103166043core:FurnitureFittingsToolsEquipment2021-03-3103166043core:FurnitureFittingsToolsEquipment2021-04-012022-03-3103166043core:FurnitureFittingsToolsEquipment2022-03-31

HILTON PHARMACY LIMITED

Registered Number
03166043
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2022

HILTON PHARMACY LIMITED
Company Information
for the year from 1 April 2021 to 31 March 2022

Directors

M R Bhojani
N N Ebrahim

Registered Address

Flat 12 High Street
Desborough
Kettering
NN14 2QS

Registered Number

03166043 (England and Wales)
HILTON PHARMACY LIMITED
Balance Sheet as at
31 March 2022

Notes

2022

2021

£

£

£

£

Fixed assets
Tangible assets721,87216,627
21,87216,627
Current assets
Stocks847,34039,200
Debtors9252,480226,822
Cash at bank and on hand78,90280,670
378,722346,692
Creditors amounts falling due within one year10(198,877)(171,845)
Net current assets (liabilities)179,845174,847
Total assets less current liabilities201,717191,474
Net assets201,717191,474
Capital and reserves
Called up share capital100100
Profit and loss account201,617191,374
Shareholders' funds201,717191,474
The financial statements were approved and authorised for issue by the Board of Directors on 19 August 2022, and are signed on its behalf by:
M R Bhojani
Director
N N Ebrahim
Director

Registered Company No. 03166043
HILTON PHARMACY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2022

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
4.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings20
Fixtures and fittings15
Vehicles25
Office Equipment25
Intangible assets policy
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
5.Employee information

20222021
Average number of employees during the year97
6.Intangible assets
7.Property, plant and equipment

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

££££££
Cost or valuation
At 01 April 214,655-1,50067,7469,90083,801
Additions----8,7898,789
At 31 March 224,655-1,50067,74618,68992,590
Depreciation and impairment
At 01 April 214,655-94754,2957,27767,174
Charge for year-3,406138--3,544
At 31 March 224,6553,4061,08554,2957,27770,718
Net book value
At 31 March 22-(3,406)41513,45111,41221,872
At 31 March 21--55313,4512,62316,627
8.Stocks

2022

2021

££
Raw materials and consumables47,34039,200
Total47,34039,200
9.Debtors

2022

2021

££
Trade debtors / trade receivables133,302207,284
Other debtors118,98719,084
Prepayments and accrued income191454
Total252,480226,822
10.Creditors within one year

2022

2021

££
Trade creditors / trade payables122,975108,003
Taxation and social security4,56428,294
Other creditors71,33835,548
Total198,877171,845
11.Creditors after one year